Advertisement

Aminolevulinic Acid: Actinic Keratosis and Photorejuvenation

  • Melanie Palm
  • Mitchel P. Goldman
Chapter

Abstract

ALA-PDT is a safe and effective treatment for nonhyperkeratotic lesions. Although FDA-approved for use with a blue light source, other laser and light sources have demonstrated promise in the treatment of actinic keratosis during PDT. Shorter incubation times maintain AK clearance rates but decrease the occurrence of phototoxic adverse events. With careful patient selection, ALA-PDT allows selective field treatment of precancerous skin lesions with improvement in overall photodamage. Patient satisfaction is high and cosmetic results can be excellent.

Keywords

Clearance Rate Actinic Keratose Intense Pulse Light Dorsal Hand Skin Texture 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Calzavara-Pinton PG, Venturini M, Sala R. Photo­dynamic therapy: update 2006. Part 1: photochemistry and photobiology. J Eur Acad Dermatol Venereol. 2007;21:293–302.PubMedCrossRefGoogle Scholar
  2. 2.
    Nootheti PK, Goldman MP. Aminolevulinic acid-photodynamic therapy for photorejuvenation. Dermatol Clin. 2007;25:35–45.PubMedCrossRefGoogle Scholar
  3. 3.
    Ericson MB, Sandberg C, Stenquist B, Gudmundson F, et al. Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome. Br J Dermatol. 2004;151:1204–12.PubMedCrossRefGoogle Scholar
  4. 4.
    Nakaseko H, Kobayashi M, Akita Y, Tamada Y, et al. Histological changes and involvement of apoptosis after photodynamic therapy for actinic keratoses. Br J Dermatol. 2003;148:122–7.PubMedCrossRefGoogle Scholar
  5. 5.
    Wolf P, Rieger E, Kerl H. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. J Am Acad Dermatol. 1993;28:17–21.PubMedCrossRefGoogle Scholar
  6. 6.
    Touma D, Yaar M, Whitehead S, Konnikov N, et al. A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage. Arch Dermatol. 2004;140:33–40.PubMedCrossRefGoogle Scholar
  7. 7.
    Tsai T, Ji HT, Chiang PC, Chou RH, Chang WSW, Chen CT. ALA-PDT results in phenotypic changes and decreased cellular invasion in surviving cancer cells. Lasers Surg Med. 2009;41:305–15.PubMedCrossRefGoogle Scholar
  8. 8.
    MacCormack MA. Photodynamic therapy in dermatology: an update on applications and outcomes. Semin Cutan Med Surg. 2008;27:52–62.PubMedCrossRefGoogle Scholar
  9. 9.
    Nestor MS, Gold MH, Kauvar ANB, Taub AF, et al. The use of photodynamic therapy in dermatology: results of a consensus conference. J Drugs Dermatol. 2006;5:140–54.PubMedGoogle Scholar
  10. 10.
    Product information (package insert): Levulan (R) Kerastick (TM) (aminolevulinic acid HCl) for topical solution, 20%. DUSA Pharmaceuticals, Inc., Wilmington, MA, USA; 2009.Google Scholar
  11. 11.
    Fotinos N, Campo MA, Popowycz F, Gurny R, et al. 5-Aminolevulinic acid derivatives in photomedicine: characteristics, application and perspectives. Photochem Photobiol. 2006;82:994–1015.PubMedCrossRefGoogle Scholar
  12. 12.
    Kalka K, Merk H, Mukhtar H. Photodynamic therapy in dermatology. J Am Acad Dermatol. 2000;42:389–413.PubMedCrossRefGoogle Scholar
  13. 13.
    Gaullier JM, Berg K, Peng Q, Anholt H, et al. Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture. Cancer Res. 1997;57:1481–6.PubMedGoogle Scholar
  14. 14.
    Peng Q, Warloe T, Berg K, Moan J, et al. 5-Aminolevulinic acid-based photodynamic therapy. Cancer. 1997;79:2282–308.PubMedCrossRefGoogle Scholar
  15. 15.
    Kasche A, Luderschmidt S, Ring J, Hein R. Photodynamic therapy induces less pain in patients treated with methyl aminolevulinate compared to aminolevulinic acid. J Drugs Dermatol. 2006;5:353–6.PubMedGoogle Scholar
  16. 16.
    Goldberg DJ. Photodynamic therapy in skin rejuvenation. Clin Dermatol. 2008;26:608–13.PubMedCrossRefGoogle Scholar
  17. 17.
    Nakano A, Tamada Y, Watanabe D, Ishida N, et al. A pilot study to assess the efficacy of photodynamic therapy for Japanese patients with actinic keratosis in relation to lesion size and histological severity. Photodermatol Photoimmunol Photomed. 2009;25: 37–40.PubMedCrossRefGoogle Scholar
  18. 18.
    Zakhary K, Ellis DAF. Applications of aminolevulinic acid-based photodynamic therapy in cosmetic facial plastic practices. Facial Plast Surg. 2005;21:110–6.PubMedCrossRefGoogle Scholar
  19. 19.
    Clark C, Bryden A, Dawe R, Moseley H, et al. Topical 5-aminolevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources. Photodermatol Photoimmunol Photomed. 2003;19:134–41.PubMedCrossRefGoogle Scholar
  20. 20.
    DeHoratius DM, Dover JS. Nonablative tissue remodeling and photorejuvenation. Clin Dermatol. 2007;25:474–9.PubMedCrossRefGoogle Scholar
  21. 21.
    Markham T, Collins P. Topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratoses. Br J Dermatol. 2001;145:502–4.PubMedCrossRefGoogle Scholar
  22. 22.
    Kalisiak MS, Rao J. Photodynamic therapy for actinic keratoses. Dermatol Clin. 2007;25:15–23.PubMedCrossRefGoogle Scholar
  23. 23.
    Gold MH. Pharmacoeconomic analysis of the treatment of multiple actinic keratoses. J Drugs Dermatol. 2008;7:23–5.PubMedGoogle Scholar
  24. 24.
    Drake LA, Ceilley RI, Cornelison RL, et al. Guidelines of care for AKs. J Am Acad Dermatol. 1995; 32:95–8.PubMedCrossRefGoogle Scholar
  25. 25.
    Stockfleth E, Kerl H. Guidelines for the management of actinic keratoses. Eur J Dermatol. 2006;16: 599–606.PubMedGoogle Scholar
  26. 26.
    Lehmann P. Methyl aminolaevulinate-photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer. Br J Dermatol. 2007;156:793–801.PubMedCrossRefGoogle Scholar
  27. 27.
    Berking C, Herzinger T, Flaig MJ, Brenner M, Borelli C, Degitz K. The efficacy of photodynamic therapy in actinic cheilitis of the lower lip: a prospective study of 15 patients. Dermatol Surg. 2007;33:825–30.PubMedCrossRefGoogle Scholar
  28. 28.
    Marks R. Epidemiology of nonmelanoma skin cancer and solar keratoses in Australia: a tale of self-immolation in Elysian fields. Australas J Dermatol. 1997;38:S26–9.PubMedCrossRefGoogle Scholar
  29. 29.
    Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol. 2002;146:1–6.PubMedCrossRefGoogle Scholar
  30. 30.
    Osborne JE. Skin cancer screening and surveillance. Br J Dermatol. 2002;146:745–54.PubMedCrossRefGoogle Scholar
  31. 31.
    Marks R, Rennie G, Selwood TS. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet. 1988;1:795–7.PubMedCrossRefGoogle Scholar
  32. 32.
    Glogau RG. The risk of progression to invasive disease. J Am Acad Dermatol. 2000;42(1 Pt 2):23–4.PubMedCrossRefGoogle Scholar
  33. 33.
    Czarnecki D, Meehan CJ, Bruce F, Culjak G. The majority of cutaneous squamous cell carcinomas arise in actinic keratoses. J Cutan Med Surg. 2002;6:207–9.PubMedCrossRefGoogle Scholar
  34. 34.
    Cockerell CJ, Wharton JR. New histopathological classification of actinic keratosis (incipient intraepithelial squamous cell carcinoma). J Drugs Dermatol. 2005;4:462–7.PubMedGoogle Scholar
  35. 35.
    Ortonne JP. From actinic keratoses to squamous cell carcinoma. Br J Dermatol. 2002;146:S20–3.CrossRefGoogle Scholar
  36. 36.
    Hurwitz RM, Monger LE. Solar keratosis: an evolving squamous cell carcinoma. Benign or malignant? Dermatol Surg. 1995;21:184.PubMedCrossRefGoogle Scholar
  37. 37.
    Moy RL. Clinical presentation of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol. 2000;42:8–10.PubMedCrossRefGoogle Scholar
  38. 38.
    Bäumler W, Wetzig T. Clinical application of fluorescence diagnosis. In: Goldman MP, Dover JS, Alam M, editors. Procedures in cosmetic dermatology: photodynamic therapy. 2nd ed. Philadelphia, PA: Elsevier; 2008. p. 149–60.Google Scholar
  39. 39.
    Salasche SJ. Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol. 2000;42:4–7.PubMedCrossRefGoogle Scholar
  40. 40.
    Cockerell CJ. Histopathology of incipient intraepidermal squamous cell carcinoma (“actinic keratosis”). J Am Acad Dermatol. 2000;42:11–7.PubMedCrossRefGoogle Scholar
  41. 41.
    Tschen EH, Wong DS, Pariser DM, Dunlap FE, Houlihan A, Ferdon MB. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV mulicentre clinical trial with 12-month follow up. Br J Dermatol. 2006;155:1262–9.PubMedCrossRefGoogle Scholar
  42. 42.
    Jeffes EW, McCullough JL, Weinstein GD, Kaplan R, Glazer SD, Taylor JR. Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light. J Am Acad Dermatol. 2001;45:96–104.PubMedCrossRefGoogle Scholar
  43. 43.
    Szeimies RM, Karrer S, Radakovic-Fijan S, Tanew A, Galzavara-Pinton PG, Zane C, et al. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: a prospective, randomized study. J Am Acad Dermatol. 2002;47:258–62.PubMedCrossRefGoogle Scholar
  44. 44.
    Kurwa HA, Yong-Gee SA, Seed PT, et al. A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses. J Am Acad Dermatol. 1999;41:414–8.PubMedCrossRefGoogle Scholar
  45. 45.
    Tierney EP, Eide MJ, Jacobsen G, Ozog D. Photodynamic therapy for actinic keratoses: survey of patient perceptions of treatment satisfaction and outcomes. J Cosmet Laser Ther. 2008;10:81–6.PubMedCrossRefGoogle Scholar
  46. 46.
    Goldman MP, Atkin DH. ALA/PDT in the treatment of actinic keratosis: spot versus confluent therapy. J Cosmet Laser Ther. 2003;5:107–10.PubMedCrossRefGoogle Scholar
  47. 47.
    Alexiades-Amenakas MR, Geronemus RG. Laser-mediated photodynamic therapy of actinic keratoses. Arch Dermatol. 2003;139:1313–20.CrossRefGoogle Scholar
  48. 48.
    Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B. 1990;6:143–8.PubMedCrossRefGoogle Scholar
  49. 49.
    Dijkstra AT, Majoie IML, van Dongen JWF, van Weelden H, et al. Photodynamic therapy with violet light and topical δ-aminolaevulinic acid in the treatment of actinic keratosis, Bowen’s disease and basal cell carcinoma. J Eur Acad Dermatol Venereol. 2001;15:550–4.PubMedCrossRefGoogle Scholar
  50. 50.
    Ross EV, Anderson RR. Laser-tissue interactions. In: Goldman MP, editor. Cutaneous and cosmetic laser surgery. Philadelphia, PA: Elsevier; 2006. p. 1–26.Google Scholar
  51. 51.
    Ormrod D, Jarvis B. Topical aminolevulinic acid HCl photodynamic therapy. Am J Clin Dermatol. 2000;2: 133–9.CrossRefGoogle Scholar
  52. 52.
    Piacquadio DJ, Chen DM, Farber HF, et al. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials. Arch Dermatol. 2004;140:41–6.PubMedCrossRefGoogle Scholar
  53. 53.
    Gold MH. The evolving role of aminolevulinic acid hydrochloride with photodynamic therapy in ­photoaging. Cutis. 2002;69:8–13.PubMedGoogle Scholar
  54. 54.
    Fritsch C, Stege H, Saalmann G, Goerz G, et al. Green light is effective and less painful than red light in photodynamic therapy of facial solar keratoses. Photodermatol Photoimmunol Photomed. 1997;13: 181–5.PubMedGoogle Scholar
  55. 55.
    Smith S, Piacquadio D, Morhenn V, Atkin D. Short incubation PDT versus 5-FU in treating actinic keratoses. J Drugs Dermatol. 2003;2:629–35.PubMedGoogle Scholar
  56. 56.
    Jeffes WJ, McCullagh JL, Weinstein GD, Fergin PE, et al. Photodynamic therapy of actinic keratosis with topical 5-aminolaevulinic acid. Arch Dermatol. 1997;133:727–32.PubMedCrossRefGoogle Scholar
  57. 57.
    Karrer S, Bäumler W, Abels C, Hohenleutner U, et al. Long-pulse dye laser for photodynamic therapy: investigations in vitro and in vivo. Lasers Surg Med. 1999;25:51–9.PubMedCrossRefGoogle Scholar
  58. 58.
    Itoh Y, Nineomiya Y, Henta T, Tajima S, et al. Topical delta-aminolevulinic acid-based photodynamic therapy for Japanese actinic keratoses. J Dermatol. 2000;27:513–8.PubMedGoogle Scholar
  59. 59.
    Varma S, Wilson H, Kurwa HA, Gambles B, et al. Bowen’s disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large-field incoherent light source. Br J Dermatol. 2001;144:56–574.CrossRefGoogle Scholar
  60. 60.
    Moseley H, Ibbotson S, Woods J, Brancaleon L, Lesar A, Goodman C, et al. Clinical and research applications of photodynamic therapy in dermatology: experience of the Scottish PDT centre. Lasers Surg Med. 2006;38:403–16.PubMedCrossRefGoogle Scholar
  61. 61.
    Fink-Puches R, Hofer A, Smolle J, Kerl H, et al. Primary clinical response and long-term follow-up of solar keratoses treated with topically applied 5-aminolevulinic acid and irradiation by different wave bands of light. J Photochem Photobiol B. 1997; 41:145–51.PubMedCrossRefGoogle Scholar
  62. 62.
    Kim HS, Yoo JY, Cho KH, Kwon OS, et al. Topical photodynamic therapy using intense pulsed light for treatment of actinic keratosis: clinical and histopathologic evaluation. Dermatol Surg. 2005;31:33–7.PubMedCrossRefGoogle Scholar
  63. 63.
    Gilbert D. Treatment of actinic keratoses with sequential combination of 5-fluorouracil and photodynamic therapy. J Drugs Dermatol. 2005;4:161–3.PubMedGoogle Scholar
  64. 64.
    Shaffelburg M. Treatment of actinic keratoses with sequential use of photodynamic therapy and imiquimod 5% cream. J Drugs Dermatol. 2009;8:35–9.PubMedGoogle Scholar
  65. 65.
    Ruiz-Rodriguez R, Sanz-Sánchez T, Córdoba S. Photodynamic photorejuvenation. Dermatol Surg. 2002;28:742–4.PubMedCrossRefGoogle Scholar
  66. 66.
    Dover JS, Bhatia AC, Stewart B, Arndt KA. Topical 5-aminolevulinic acid combined with intense pulsed light in the treatment of photoaging. Arch Dermatol. 2005;141:1247–52.PubMedCrossRefGoogle Scholar
  67. 67.
    Zane C, Capezzera R, Sala R, Venturini M, Calzavara-Pinton P. Clinical and echographic analysis of photodynamic therapy using methylaminolevulinate as sensitizer in the treatment of photodamaged facial skin. Lasers Surg Med. 2007;39:203–9.PubMedCrossRefGoogle Scholar
  68. 68.
    Gold MH, Bradshaw VL, Boring MM, Bridges TM, et al. Split-face comparison of photodynamic therapy with 5-aminolevulinic acid and intense pulsed light versus intense pulsed light alone for photodamage. Dermatol Surg. 2006;32:795–803.PubMedCrossRefGoogle Scholar
  69. 69.
    Uebelhoer NS, Dover J. Photodynamic therapy for cosmetic applications. Dermatol Ther. 2005;18: 242–52.PubMedCrossRefGoogle Scholar
  70. 70.
    Jeffes EWB. Levulan: the first approved topical ­photosensitizer for the treatment of actinic keratosis. J Dermatol Treat. 2002;13:S19–23.CrossRefGoogle Scholar
  71. 71.
    Pariser DM, Lowe NJ, Stewart DM, Jarratt MT, et al. Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J Am Acad Dermatol. 2003;48:227–32.PubMedCrossRefGoogle Scholar
  72. 72.
    Lowe NJ, Lowe P. Pilot study to determine the efficacy of ALA-PDT photorejuvenation for the treatment of facial ageing. J Cosmet Laser Ther. 2005;7: 159–62.PubMedCrossRefGoogle Scholar
  73. 73.
    Goldberg DJ. New collagen formation after dermal remodeling with intense pulsed light sources. J Cutan Laser Ther. 2000;2:59–61.PubMedGoogle Scholar
  74. 74.
    Avram DK, Goldman MP. Effectiveness and safety of ALA-IPL in treating actinic keratoses and photodamage. J Drugs Dermatol. 2004;3:S36–9.PubMedGoogle Scholar
  75. 75.
    Alster TS, Tanzi EL, Welch EC. Photorejuvenation of facial skin with topical 20% 5-aminolevulinic acid and intense pulsed light treatment: a split-face comparison study. J Drugs Dermatol. 2005;4:35–8.PubMedGoogle Scholar
  76. 76.
    Marmur ES, Phelps R, Goldberg DJ. Ultrastructural changes seen after ALA-IPL photorejuvenation: a pilot study. J Cosmet Laser Ther. 2005;7:21–4.PubMedCrossRefGoogle Scholar
  77. 77.
    Serrano G, Lorente M, Reyes M, Millán F, et al. Photodynamic therapy with low-strength ALA, repeated applications and short contact periods (40-60 minutes) in acne, photoaging, and vitiligo. J Drugs Dermatol. 2009;8:562–8.PubMedGoogle Scholar
  78. 78.
    Key DJ. Aminolevulinic acid-pulsed dye laser photodynamic therapy for the treatment of photoaging. Cosmet Dermatol. 2005;18:31–6.Google Scholar
  79. 79.
    Oseroff A. PDT as a cytotoxic agent and biological response modifier: implications for cancer prevention and treatment in immunosuppressed and immunocompetent patients. J Invest Dermatol. 2006;126:542–4.PubMedCrossRefGoogle Scholar
  80. 80.
    Dragieva G, Hafner J, Dummer R, Schmid-Grendelmeier P, et al. Topical photodynamic therapy in the treatment of actinic keratoses and Bowen’s disease in transplant recipients. Transplantation. 2004;17:115–21.CrossRefGoogle Scholar
  81. 81.
    de Graaf YGL, Kennedy C, Wolterbeek R, Collen AFS, et al. Photodynamic therapy does not prevent cutaneous squamous-cell carcinoma in organ-transplant recipients: results of a randomized-controlled trial. J Invest Dermatol. 2006;126:569–74.PubMedCrossRefGoogle Scholar
  82. 82.
    Lee WR, Tsai RY, Fang CL, Liu CJ, Hu CH, Fang JY. Microdermabrasion as a novel tool to enhance drug delivery via the skin: an animal study. Dermatol Surg. 2006;32:1013–22.PubMedCrossRefGoogle Scholar
  83. 83.
    Katz BE, Truong S, Maiwald DC, Frew KE, George BA. Efficacy of microdermabrasion preceding ALA application in reducing the incubation time of ALA in laser PDT. J Drugs Dermatol. 2007;6:140–2.PubMedGoogle Scholar
  84. 84.
    Morton S, Campbell S, Gupta G, Keohane S, Lear J, Zaki I, et al. Intraindividual, right-left comparison of topical methyl aminolaevulinate photodynamic therapy and cryotherapy in subjects with actinic keratoseis: a multicentre, randomized controlled study. Br J Dermatol. 2006;155:1029–36.PubMedCrossRefGoogle Scholar
  85. 85.
    Morton CA, Whitehurst C, Moseley H, et al. Development of an alternative light source to lasers for photodynamic therapy: clinical evaluation in the treatment of pre-malignant non-melanoma skin cancer. Lasers Med Sci. 1995;10:165–71.CrossRefGoogle Scholar
  86. 86.
    Fijan S, Honigsmann H, Ortel B. Photodynamic therapy of epithelial skin tumors with delta-aminolaevulinic acid and desferrioxamine. Br J Dermatol. 1995;133:282–8.PubMedCrossRefGoogle Scholar
  87. 87.
    Szeimies RM, Karrer S, Sauerwald A, Landthaler M. Photodynamic therapy with topical application of 5-aminolevulinic acid in the treatment of actinic keratoses: an initial clinical study. Dermatology. 1996;192: 246–51.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Surfside DermatologyEncinitasUSA

Personalised recommendations